BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26568955)

  • 1. The Significance of Metastasectomy in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy.
    Yu X; Wang B; Li X; Lin G; Zhang C; Yang Y; Fang D; Song Y; He Z; Zhou L
    Biomed Res Int; 2015; 2015():176373. PubMed ID: 26568955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma.
    Tosco L; Van Poppel H; Frea B; Gregoraci G; Joniau S
    Eur Urol; 2013 Apr; 63(4):646-52. PubMed ID: 23041360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of metastasectomy on prognosis in patients treated with targeted therapy for metastatic renal cell carcinoma.
    You D; Lee C; Jeong IG; Song C; Lee JL; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2331-8. PubMed ID: 27553579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastasectomy with standardized lymph node dissection for metastatic renal cell carcinoma: an 11-year single-center experience.
    Kudelin N; Bölükbas S; Eberlein M; Schirren J
    Ann Thorac Surg; 2013 Jul; 96(1):265-70: discussion 270-1. PubMed ID: 23731615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of the primary tumor on the long-term results of pulmonary metastasectomy for metastatic renal cell carcinoma.
    Bölükbas S; Kudelin N; Eberlein M; Fisseler-Eckhoff A; Schirren J
    Thorac Cardiovasc Surg; 2012 Sep; 60(6):390-7. PubMed ID: 22207364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Local Intervention Combined with Targeted Therapy on Metastatic Renal Cell Carcinoma.
    Li JR; Ou YC; Yang CK; Wang SS; Chen CS; Ho HC; Cheng CL; Yang CR; Chen CC; Wang SC; Lin CY; Hung SC; Hsu CY; Chiu KY
    Anticancer Res; 2018 Sep; 38(9):5339-5345. PubMed ID: 30194186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for recurrence after complete metastasectomy in patients with metastatic renal cell carcinoma in the targeted therapy era.
    Takagi T; Fukuda H; Ishihara H; Yoshida K; Kondo T; Kobayashi H; Iizuka J; Okumi M; Ishida H; Omae K; Tanabe K
    Urol Oncol; 2020 May; 38(5):515-520. PubMed ID: 32146128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective survival analysis of 237 consecutive patients with multiple pulmonary metastases from advanced renal cell carcinoma exclusively resected by a 1318-nm laser.
    Baier B; Kern A; Kaderali L; Bis B; Koschel D; Rolle A
    Interact Cardiovasc Thorac Surg; 2015 Aug; 21(2):211-7. PubMed ID: 25977131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma.
    Hofmann HS; Neef H; Krohe K; Andreev P; Silber RE
    Eur Urol; 2005 Jul; 48(1):77-81; discussion 81-2. PubMed ID: 15967255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).
    Antonelli A; Arrighi N; Corti S; Legramanti S; Zanotelli T; Cozzoli A; Cunico SC; Simeone C
    BJU Int; 2012 Dec; 110(11 Pt B):E559-63. PubMed ID: 22639956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors, utilization patterns, and overall survival of patients undergoing metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy.
    Sun M; Meyer CP; Karam JA; de Velasco G; Chang SL; Pal SK; Trinh QD; Choueiri TK
    Eur J Surg Oncol; 2018 Sep; 44(9):1439-1445. PubMed ID: 29935840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic lymph node dissection in lung metastasectomy of renal cell carcinoma: an 18 years of experience.
    Renaud S; Falcoz PE; Alifano M; Olland A; Magdeleinat P; Pagès O; Regnard JF; Massard G
    J Surg Oncol; 2014 Jun; 109(8):823-9. PubMed ID: 24619772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of metastasectomy in metastatic renal cell carcinoma.
    Thomas AZ; Adibi M; Borregales LD; Wood CG; Karam JA
    Curr Opin Urol; 2015 Sep; 25(5):381-9. PubMed ID: 26125508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended hepatic metastasectomy for renal cell carcinoma-new aspects in times of targeted therapy: a single-center experience over three decades.
    Beetz O; Söffker R; Cammann S; Oldhafer F; Vondran FWR; Imkamp F; Klempnauer J; Kleine M
    Langenbecks Arch Surg; 2020 Feb; 405(1):97-106. PubMed ID: 31938833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes Following Complete Surgical Metastasectomy for Patients with Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Zaid HB; Parker WP; Safdar NS; Gershman B; Erwin PJ; Murad MH; Boorjian SA; Costello BA; Thompson RH; Leibovich BC
    J Urol; 2017 Jan; 197(1):44-49. PubMed ID: 27473875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma?
    Kwak C; Park YH; Jeong CW; Lee SE; Ku JH
    Urol Oncol; 2007; 25(4):310-6. PubMed ID: 17628297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgery for metastases of renal cell carcinoma: outcome of treatments and preliminary assessment of Leuven-Udine prognostic groups in the targeted therapy era.
    Tornberg SV; Visapää H; Kilpeläinen TP; Taari K; Järvinen R; Erkkilä K; Nisen H; Järvinen P
    Scand J Urol; 2018; 52(5-6):419-426. PubMed ID: 30663485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable.
    Vogl UM; Zehetgruber H; Dominkus M; Hejna M; Zielinski CC; Haitel A; Schmidinger M
    Br J Cancer; 2006 Sep; 95(6):691-8. PubMed ID: 16940978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications and surgical outcome following pulmonary metastasectomy: a nationwide study.
    Vidarsdottir H; Moller PH; Jonasson JG; Pfannschmidt J; Gudbjartsson T
    Thorac Cardiovasc Surg; 2012 Sep; 60(6):383-9. PubMed ID: 22215491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of metastasectomy in renal cell carcinoma in the postcytokine therapy era.
    Ishihara H; Takagi T; Kondo T; Fukuda H; Tachibana H; Yoshida K; Iizuka J; Kobayashi H; Ishida H; Tanabe K
    Urol Oncol; 2021 Jan; 39(1):77.e17-77.e25. PubMed ID: 32863124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.